Ines N Benis, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 815 K St, Hoquiam, WA 98550 Phone: 360-533-2734 Fax: 360-532-2748 |
News Archive
Scientists at The Scripps Research Institute have made a breakthrough in understanding a class of cells that help wounds in skin and other epithelial tissues heal, uncovering a molecular mechanism that pushes the body into wound-repair mode.
The protease inhibitor lopinavir - the primary component of Abbott Laboratories' antiretroviral drug Kaletra - selectively killed the human papillomavirus in laboratory tests, according to a study scheduled to be published next month in the journal Anti-Viral Therapy.
Scientists at the University of Virginia School of Medicine have identified a potential way to head off heart attacks and strokes by strengthening the fibrous caps overlying atherosclerotic plaques that naturally accumulate inside our arteries.
Synthetic Biologics, Inc., a developer of pathogen-specific therapies for serious infections and diseases, with a focus on protecting the microbiome, today announced positive topline safety and tolerability results from a Phase 1b clinical trial of SYN-004, the Company's investigational oral beta-lactamase enzyme designed to protect the microbiome and prevent Clostridium difficile (C. difficile) infection, antibiotic-associated diarrhea and secondary antibiotic-resistant infections in patients receiving intravenous (IV) beta-lactam antibiotic therapy.
The Institute of Medicine Wednesday urged a series regulatory changes to help protect the public against buying fake or poorly made drugs.
› Verified 6 days ago